http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-362679-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_232361c9031a709144573276863c462b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B7-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B7-22 |
| filingDate | 1969-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1971-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-362679-A1 |
| titleOfInvention | A PROCEDURE FOR THE PREPARATION OF NEW ANTI-INFLAMMATORY STEROIDS, OF THE PREGNANE SERIES. |
| abstract | Pharmaceutical compositions contain antiinflammatory steroids of the formula (wherein (a) X is #-OH, R1 is F, Cl, Br or I R2 is C 2-4 alkanoyl, R3 is CH 3 or =CH 2 , Y is F or, when R2 is C 2-3 alkanoyl, can also be Cl, and #1 is optional or (b) X is 0, R1 and R2 are as in (a), R3 is CH 3 or, when R1 is F, can also be =CH 2 , Y is F and #1 is optional or (c) R1 is Y are F, R3 is #-CH 3 , X is #-OH, R2 is valeryl and #1 is present) and suitable carriers or excipients. They may be in forms for topical or internal use and may contain anti-microbial agents, particularly antibiotics such as neomycin, and preservatives or bacteriostatic agents. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2078175-A1 |
| priorityDate | 1968-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673796 |
Total number of triples: 16.